GO
Loading...

Bristol-Myers Executive Charged With Insider Trading

FBI agents arrested Robert Ramnarine, a Bristol-Myers Squibbexecutive, on Thursday. He has been criminally charged with insider trading the call options of companies shortly before they were acquired, court papers show.

CNBC.com

Ramnarine, an assistant director for capital markets in Bristol-Myers' office in Princeton, N.J., was arrested by agents at a suburban New Jersey home this morning.

A three-count criminal complaint was unsealed this morning. According the complaint, he made more than $311,000 in illegal profit.

The insider trading in question involved several stocks, including ZymoGenetics, Pharmasset and Amylin Pharmaceuticals.

Ramnarine will have his initial court appearance later this afternoon. It is unclear whether Ramnarine has hired a lawyer for his defense.

In his position at Bristol-Myers Squibb, he was responsible for conducting due diligence concerning the pension plans of the company's acquisition targets.

No immediate response from Bristol-Myers Squibb was available.

— By CNBC's Jim Forkin. Reuters contributed to this article.

Symbol
Price
 
Change
%Change
BMY
---

Featured

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • NBC News' Martin Fletcher reports on the back and forth blame of who shot airstrikes which fell short of their targets and hit a children's park, as well as a main hospital compound in Gaza.

  • The "Earnings Squad" discuss the expectations for earnings from Aetna, UPS, TRW Automotive, and Wynn Resorts, with CNBC's Brian Sullivan, Melissa Lee, Bertha Coombs and FMHR trader Stephanie Link.

  • From jobs data to the Fed announcement, what's most important for investors? Jack Ablin, BMO Private Bank EVP & CIO, and Matthew McCormick, Bahl & Gaynor principal, provide perspective.